Mortality and Glycemic Control Among Patients With Diabetes Mellitus and Uterine Or Ovarian Cancer
Yael Kusne(WinnMed), Nina J. Karlin(Mayo Clinic Hospital), Heidi Kosiorek(Mayo Clinic in Florida), Patricia M Verona(Mayo Clinic in Arizona), Curtiss B. Cook(Mayo Clinic in Arizona), Kyle Coppola(James A. Haley Veterans' Hospital), Matthew Buras
Cited by 8
Related Papers
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
|Journal of Clinical Investigation|2020|485
Safety Update
|Mayo Clinic Proceedings|2020|432
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
|Journal of Diabetes Science and Technology|2022|288